Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | THPO | P40225 | 1/20 | 0.40 |
| ▸ | CA4 | P22748 | 2/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.31 |
| ▸ | LCK | P06239 | 1/20 | 0.31 |
| ▸ | FYN | P06241 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11422551 | 0.80 | TSHR (0.35) | TSHRTHPOCA4 | |
| SCHEMBL6573629 | 0.80 | TSHR (0.30) | TSHRTHPO | |
| SCHEMBL233035 | 0.76 | LMNA (0.46) | TSHRTHPOCA4LMNAFFAR3 | |
| SCHEMBL543507 | 0.76 | FFAR3 (0.38) | LMNAFFAR3LCKFYN | |
| SCHEMBL4816778 | 0.73 | TDP1 (0.40) | TSHRCA4 | |
| SCHEMBL9140583 | 0.72 | LMNA (0.42) | TSHRTHPOCA4LMNAFFAR3 | |
| SCHEMBL3464595 | 0.72 | LMNA (0.42) | TSHRTHPOCA4LMNAFFAR3 | |
| SCHEMBL4347148 | 0.72 | LMNA (0.42) | TSHRTHPOCA4LMNAFFAR3 | |
| SCHEMBL30874330 | 0.72 | LMNA (0.42) | TSHRTHPOCA4LMNAFFAR3 | |
| SCHEMBL9841055 | 0.72 | LMNA (0.42) | TSHRTHPOCA4LMNAFFAR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 116 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240328935-A1 | Method and system for monitoring the quality of a fermentation process for beer | DAUSCH MANFRED (DE) | 2024-10-03 | — | — | US | claimed |
| EP-4370912-A1 | METHOD AND SYSTEM FOR MONITORING THE QUALITY OF A FERMENTATION PROCESS FOR BEER | Dausch, Manfred (DE) | 2024-05-22 | — | — | EP | claimed |
| EP-4231848-A1 | HEAT TREATED PULSE FLOURS | Eat Just, Inc. (US) | 2023-08-30 | — | — | EP | claimed |
| CN-116669572-A | Heat treated soy flour | 皆食得公司 | 2023-08-29 | — | — | CN | claimed |
| WO-2023285683-A1 | METHOD AND SYSTEM FOR MONITORING THE QUALITY OF A FERMENTATION PROCESS FOR BEER | DAUSCH MANFRED (DE) | 2023-01-19 | — | — | WO | claimed |
| WO-2022087130-A1 | HEAT TREATED PULSE FLOURS | EAT JUST, INC. (US) | 2022-04-28 | — | — | WO | claimed |
| US-20220118458-A1 | HEAT TREATED PULSE FLOURS | AHIMSA FOUNDATION, AS COLLATERAL AGENT | 2022-04-21 | — | — | US | claimed |
| EP-3956451-A1 | APTAMERS FOR ODOR CONTROL APPLICATIONS | The Procter & Gamble Company (US) | 2022-02-23 | — | — | EP | claimed |
| EP-4739648-A1 | PHOTOISOMERIZATION OF GERANIAL AND NERAL | BASF SE (DE) | 2026-05-13 | — | — | EP | disclosed |
| US-20260060924-A1 | SEMI-SOLID ORAL DOSAGE FORM WITH ENCAPSULATED ACTIVE INGREDIENT | CONCEPT MATRIX SOLUTIONS (US) | 2026-03-05 | — | — | US | disclosed |
| EP-4082547-B1 | SYSTEMS, METHODS, AND COMPOSITIONS FOR CROSS-LINKING TREATMENTS OF AN EYE | AVEDRO INC (US) | 2026-02-04 | — | — | EP | disclosed |
| EP-4673523-A1 | LOW DIACETYL YEAST PROGENY STRAINS | Carlsberg A/S (DK) | 2026-01-07 | — | — | EP | disclosed |
| EP-4180799-B1 | METHOD OF CLASSIFYING MILK | PPB TECH PTY LTD (AU) | 2025-12-24 | — | — | EP | disclosed |
| US-20250296907-A1 | METHOD FOR OBTAINING ACETOIN | LESAFFRE ET COMPAGNIE (FR) | 2025-09-25 | — | — | US | disclosed |
| US-20070265255-A1 | SYNTHESIS, STRUCTURE AND USE OF BISOXAZOLIDINES FOR ASYMMETRIC CATALYSIS AND SYNTHESIS | GEORGETOWN UNIVERSITY | 2007-11-15 | — | — | US | disclosed |
| US-20050255572-A1 | Microbial production of pyruvate and other metabolites | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) | 2005-11-17 | — | — | US | disclosed |
| EP-1063290-A1 | NOVEL DICARBONYLREDUCTASE AND GENE ENCODING THE SAME | TAISHO PHARMACEUTICAL CO., LTD (JP) | 2000-12-27 | — | — | EP | disclosed |
| US-5047405-A | Alzheimer*s disease | BIORESEARCH S.P.A. (IT) | 1991-09-10 | — | — | US | disclosed |
| EP-0290819-A2 | Pteridines suitable for the preparation of pharmaceutical compositions with antiamnesic activity | BIORESEARCH S.p.A. (IT) | 1988-11-17 | — | — | EP | disclosed |
| US-4395430-A | ALPHA-KETO DIACYLOXY COMPOUNDS | HERCULES INCORPORATED (US) | 1983-07-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260060924-A1 | SEMI-SOLID ORAL DOSAGE FORM WITH ENCAPSULATED ACTIVE INGREDIENT | ALPI, S100P, SI | TSHR 4515/4885THPO 4764/4885CA4 112/4885 |
| US-20070265255-A1 | SYNTHESIS, STRUCTURE AND USE OF BISOXAZOLIDINES FOR ASYMMETRIC CATALYSIS AND SYNTHESIS | ADH5, ADH1C, ADH1A | TSHR 2051/4885THPO 2868/4885CA4 2627/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.